Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:160-169

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lanz, C.-B.
Right arrow Articles by Mohaupt, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lanz, C.-B.
Right arrow Articles by Mohaupt, M. G.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2001;37:160.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Fluid Shear Stress Reduces 11ß-Hydroxysteroid Dehydrogenase Type 2

C.-Bettina Lanz; Maja Causevic; Christian Heiniger; Felix J. Frey; Brigitte M. Frey; Markus G. Mohaupt

From the Division of Nephrology/Hypertension, University of Berne, Berne, Switzerland.

Correspondence to Markus G. Mohaupt, MD, University Hospital Berne, Division of Nephrology/Hypertension, 3010 Berne, Switzerland. E-mail markus.mohaupt{at}insel.ch

Abstract—In pregnancy, invading trophoblasts represent the inner vascular border of maternal spiral arteries and are exposed to elevated shear stress (ss) in hypertensive disorders. Intracellular cortisol availability is regulated by 11ß-hydroxysteroid dehydrogenases (11ß-HSDs), thus determining body fluid volume and vascular responses. The impact of ss on 11ß-HSD2 activity was studied in the human JEG-3 cell line, a model for trophoblasts. JEG-3 cells do not express 11ß-HSD1; however, 11ß-HSD2 message and activity are measured via cortisol/cortisone conversion in cell lysates, and both are reduced by ss. The reduction in 11ß-HSD2 activity via ss is dose dependent and completely reversible after the discontinuation of ss. cAMP-dependent protein kinase A activation increased the 11ß-HSD2 activity yet did not prevent the ss response. The ss response was completely protein kinase C independent. The mitogen-activated protein kinase kinase inhibitor PD-098059 enhanced 11ß-HSD2 activity in static conditions yet only ameliorated the ss effect. Cytochalasin D disrupts focal adhesion (FA)-cytoskeleton interactions and abolished the ss-induced tyrosine phosphorylation of FA kinase dose-dependently, thus maintaining 11ß-HSD2 activity. The 11ß-HSD2 activity was only partially restored by the tyrosine kinase inhibitor genistein; however, herbimycin A almost completely abolished the ss effect on 11ß-HSD2 activity. In conclusion, JEG-3 cells express 11ß-HSD2, which is downregulated by ss. Regulatory mechanisms involve transcriptional control and require intact FA-cytoskeleton signaling and phosphorylation of FA kinase. Thus, ss adds to an enhanced intracellular availability of cortisol, which may ultimately support a vasoconstrictive vascular response.


Key Words: 11ß-hydroxysteroid dehydrogenase • shear stress • cortisol • hypertension • focal adhesion • cytoskeleton




This article has been cited by other articles:


Home page
FASEB J.Home page
R. Alikhani-Koupaei, F. Fouladkou, P. Fustier, B. Cenni, A. M. Sharma, H.-C. Deter, B. M. Frey, and F. J. Frey
Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity
FASEB J, November 1, 2007; 21(13): 3618 - 3628.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Yang, L. Julan, F. Rubio, A. Sharma, and H. Guan
Cadmium reduces 11{beta}-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E135 - E142.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Kadereit, P. Fustier, K. Shojaati, B. M. Frey, F. J. Frey, and M. G. Mohaupt
Extracellular ATP Determines 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Activity via Purinergic Receptors
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3507 - 3516.
[Abstract] [Full Text] [PDF]